These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7783129)

  • 1. Three-dimensional quantitative structure-activity relationships of somatostatin analogues. 1. Comparative molecular field analysis of growth hormone release-inhibiting potencies.
    Hocart SJ; Reddy V; Murphy WA; Coy DH
    J Med Chem; 1995 May; 38(11):1974-89. PubMed ID: 7783129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of iodinated somatostatin analogues selective for hsst2 and hsst5 with excellent inhibition of growth hormone and prolactin release from rat pituitary cells.
    Moore SB; van der Hoek J; de Capua A; van Koetsveld PM; Hofland LJ; Lamberts SW; Goodman M
    J Med Chem; 2005 Oct; 48(21):6643-52. PubMed ID: 16220980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides.
    Raynor K; Murphy WA; Coy DH; Taylor JE; Moreau JP; Yasuda K; Bell GI; Reisine T
    Mol Pharmacol; 1993 Jun; 43(6):838-44. PubMed ID: 8100350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative potencies of the somatostatin analogs octreotide, BIM-23014, and RC-160 on the inhibition of hormone release by cultured human endocrine tumor cells and normal rat anterior pituitary cells.
    Hofland LJ; van Koetsveld PM; Waaijers M; Zuyderwijk J; Lamberts SW
    Endocrinology; 1994 Jan; 134(1):301-6. PubMed ID: 7903931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyrosylated analogues of somatostatin.
    Rivier JE; Brown MR; Vale WW
    J Med Chem; 1976 Aug; 19(8):1010-3. PubMed ID: 966246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformational study of a series of somatostatin analogues with antitumor and/or GH inhibitory activity.
    Jaspers H; Horvåth A; Mezö I; Kéri G; Van Binst G
    Int J Pept Protein Res; 1994 Mar; 43(3):271-6. PubMed ID: 7911792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatostatin: analogs with selected biological activities.
    Brown M; Rivier J; Vale W
    Science; 1977 Jun; 196(4297):1467-9. PubMed ID: 867045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatostatin analogs which inhibit glucagon and growth hormone more than insulin release.
    Meyers C; Arimura A; Gordin A; Fernandez-Durango R; Coy DH; Schally AV; Drouin J; Ferland L; Beaulieu M; Labrie F
    Biochem Biophys Res Commun; 1977 Jan; 74(2):630-6. PubMed ID: 836315
    [No Abstract]   [Full Text] [Related]  

  • 9. [Phe4]somatostatin: a potent, selective inhibitor of growth hormone release.
    Meyers CA; Coy DH; Murphy WA; Redding TW; Arimura A; Schally AV
    Proc Natl Acad Sci U S A; 1980 Jan; 77(1):577-9. PubMed ID: 6987657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of highly potent octapeptide analogs of somatostatin on growth hormone, insulin and glucagon release.
    Karashima T; Cai RZ; Schally AV
    Life Sci; 1987 Aug; 41(8):1011-9. PubMed ID: 2886886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploration of the DTrp-NMeLys motif in the search for potent somatostatin antagonists.
    Rajeswaran WG; Murphy WA; Taylor JE; Coy DH
    Bioorg Med Chem; 2002 Jun; 10(6):2023-9. PubMed ID: 11937362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human growth hormone (GH)-releasing factor stimulates and somatostatin inhibits the release of rat GH variants.
    Yokoya S; Friesen HG
    Endocrinology; 1986 Nov; 119(5):2097-105. PubMed ID: 2876884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic hexapeptide analogs of somatostatin containing bridge modifications. Syntheses and conformational analyses.
    Huang Z; Pröbstl A; Spencer JR; Yamazaki T; Goodman M
    Int J Pept Protein Res; 1993 Oct; 42(4):352-65. PubMed ID: 7902342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of a nonreducible cyclic analog of somatostatin having only growth hormone release inhibiting activity.
    Garsky VM; Clark DE; Grant NH
    Biochem Biophys Res Commun; 1976 Dec; 73(4):911-6. PubMed ID: 15625860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological activity of glycosylated analogs of somatostatin.
    Lavielle S; Ling N; Brazeau P; Benoit R; Wasada T; Harris D; Unger R; Guillemin R
    Biochem Biophys Res Commun; 1979 Nov; 91(2):614-22. PubMed ID: 518658
    [No Abstract]   [Full Text] [Related]  

  • 16. Highly potent cyclic disulfide antagonists of somatostatin.
    Hocart SJ; Jain R; Murphy WA; Taylor JE; Coy DH
    J Med Chem; 1999 Jun; 42(11):1863-71. PubMed ID: 10354394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemistry and pharmacology of SMS 201-995, a long-acting octapeptide analogue of somatostatin.
    Pless J; Bauer W; Briner U; Doepfner W; Marbach P; Maurer R; Petcher TJ; Reubi JC; Vonderscher J
    Scand J Gastroenterol Suppl; 1986; 119():54-64. PubMed ID: 2876507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Natural peptides and their analogs. XXXV. Synthesis and properties of [Ala5, Orn9]somatostatin].
    Shvachkin IuP; Smirnova AP; Ermak NM; Fedotov VP; Sadovnikova NV
    Bioorg Khim; 1985 Aug; 11(8):1026-36. PubMed ID: 2865960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Observations on the growth hormone, insulin, and glucagon release-inhibiting activities of somatostatin analogues.
    Coy DH; Meyers C; Arimura A; Schally AV; Redding TW
    Metabolism; 1978 Sep; 27(9 Suppl 1):1407-10. PubMed ID: 683009
    [No Abstract]   [Full Text] [Related]  

  • 20. A novel somatostatin mimic with broad somatotropin release inhibitory factor receptor binding and superior therapeutic potential.
    Lewis I; Bauer W; Albert R; Chandramouli N; Pless J; Weckbecker G; Bruns C
    J Med Chem; 2003 Jun; 46(12):2334-44. PubMed ID: 12773038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.